Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

SELL
$1.26 - $1.79 $6,300 - $8,950
-5,000 Reduced 33.33%
10,000 $16,000
Q3 2023

Oct 13, 2023

BUY
$1.61 - $2.54 $8,050 - $12,700
5,000 Added 50.0%
15,000 $27,000
Q2 2023

Jul 14, 2023

BUY
$1.14 - $1.95 $11,399 - $19,500
10,000 New
10,000 $18,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Gilman Hill Asset Management, LLC Portfolio

Follow Gilman Hill Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilman Hill Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilman Hill Asset Management, LLC with notifications on news.